Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers.
about
N-glycans: phenotypic homology and structural differences between myocardial cells and induced pluripotent stem cell-derived cardiomyocytesDecreased amyloid-β pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model miceDual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation.Sialyl-lactotetra, a novel cell surface marker of undifferentiated human pluripotent stem cells.Sample preparation for mass spectrometric analysis of human serum N-glycans using hydrophilic interaction chromatography-based solid phase extraction.Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to MalignancyA Cytotoxic Antibody Recognizing Lacto-N-fucopentaose I (LNFP I) on Human Induced Pluripotent Stem (hiPS) Cells.Glycolipid dynamics in generation and differentiation of induced pluripotent stem cells.Characteristic Changes in Cell Surface Glycosylation Accompany Intestinal Epithelial Cell (IEC) Differentiation: High Mannose Structures Dominate the Cell Surface Glycome of Undifferentiated Enterocytes.Filter-aided N-glycan separation (FANGS): a convenient sample preparation method for mass spectrometric N-glycan profiling.Quantitative Assessment of Sialo-Glycoproteins and N-Glycans during Cardiomyogenic Differentiation of Human Induced Pluripotent Stem Cells.Site-specific glycosylation of the Newcastle disease virus haemagglutinin-neuraminidase.Glycomics of human embryonic stem cells and human induced pluripotent stem cells.Glycosphingolipids of human embryonic stem cells.Glycosylation and stem cells: Regulatory roles and application of iPSCs in the study of glycosylation-related disorders.Glycans define the stemness of naïve and primed pluripotent stem cells.Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.Quantitative glycomics using liquid phase separations coupled to mass spectrometry.A theoretical estimate for nucleotide sugar demand towards Chinese Hamster Ovary cellular glycosylation.Different expression levels of glycans on leukemic cells-a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid.An Efficient Glycoblotting-Based Analysis of Oxidized Lipids in Liposomes and a Lipoprotein.Quantitative analysis of total serum glycome in human and mouse.Intramolecular glycosylation.Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.Glycomics of human embryonic stem cells and human induced pluripotent stem cells.Multi-Lectin Affinity Chromatography for Separation, Identification, and Quantitation of Intact Protein Glycoforms in Complex Biological Mixtures.Comparison of the glycosphingolipids of human-induced pluripotent stem cells and human embryonic stem cells.Potentiometric Adsorption Isotherm Analysis of a Molecularly Imprinted Polymer Interface for Small-Biomolecule Recognition.Membrane glycomics reveal heterogeneity and quantitative distribution of cell surface sialylation
P2860
Q27334228-03701DFB-1EDC-41E7-B37B-42F4A9ABAC84Q34107323-DB430066-A93F-4911-8BBA-47157C4CD336Q34138890-35C740C8-DC1B-46F7-B561-3A11472FFA9CQ34420563-AB890FD0-FFB5-4055-B311-E35A20861923Q35213998-AD673E43-8B2B-414A-B4B0-D3AFA5E8D721Q35679876-2CFEABB7-A0F7-42FE-B241-E730813E9DE1Q35953063-1F122837-74CB-4F6E-B102-ED699775CEBAQ36174595-D7EA7FC2-F93E-49B1-93E4-3540B387A7D1Q36263012-EE828A23-1334-4DEC-A13D-C67379CC8A5BQ37677628-70560118-02BF-4B2F-BFBA-F9D346B45BC9Q38683295-485879F1-3698-45C7-BBC2-7C2488456306Q38785894-0DC88508-2464-43D5-80E7-1207B30B2C0BQ38869323-BDFD809E-2D10-4895-BCBA-6A77F43C718BQ38871479-338009B7-5C02-4423-BE9D-823A993D5788Q38964383-43F3D69A-9874-4DFC-96C1-C37FA9965203Q38994671-D9CAA421-142C-454B-ACAD-F7A1B41FB444Q39081304-8A2B9F65-A7C8-479D-BCEF-8C451407CCB8Q39124498-EC367BDD-1D5B-4DFD-BA2F-36EE6B598128Q39654089-6418D694-B381-4B9F-9A3C-090CAB52A27EQ41680595-40B47FE0-D399-414A-A268-99364533386BQ46325442-0789413F-AAF2-4558-B71A-9F23D4258ECFQ46465603-BEB92F7A-BA38-4C0D-8348-807B6730B7C4Q47136550-F338FBE6-C630-4F34-BF86-7A467CB60D3CQ47694823-224F0CA0-EEFA-4A14-AD26-9B827D595FAFQ49909269-83666A72-0AE2-4E2C-A014-DA4D2A6804A6Q51141522-B7B71918-3AA7-49FE-AC84-6DBFF41C629BQ53641553-4F10AEF5-5515-49CC-AC86-7D0A833DA3B1Q55654632-72040955-E9A2-409B-897D-F3DDE6A3EA10Q57767555-E5DF9DC6-AE81-41B4-A65A-7B3FE0C3A6C1
P2860
Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Total cellular glycomics allow ...... ocess for cellular biomarkers.
@ast
Total cellular glycomics allow ...... ocess for cellular biomarkers.
@en
Total cellular glycomics allow ...... ocess for cellular biomarkers.
@nl
type
label
Total cellular glycomics allow ...... ocess for cellular biomarkers.
@ast
Total cellular glycomics allow ...... ocess for cellular biomarkers.
@en
Total cellular glycomics allow ...... ocess for cellular biomarkers.
@nl
prefLabel
Total cellular glycomics allow ...... ocess for cellular biomarkers.
@ast
Total cellular glycomics allow ...... ocess for cellular biomarkers.
@en
Total cellular glycomics allow ...... ocess for cellular biomarkers.
@nl
P2093
P2860
P356
P1476
Total cellular glycomics allow ...... rocess for cellular biomarkers
@en
P2093
Jinhua Piao
Jun-ichi Furukawa
Kayo Araki
Makoto Ito
Taiki Nishioka
Toshio Nikaido
Tsuyoshi Fujioka
Yasuhiro Takegawa
Yasuro Shinohara
Yukio Nakamura
P2860
P304
P356
10.1073/PNAS.1214233110
P407
P577
2013-01-23T00:00:00Z